BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Soto M, Ramírez L, Solana JC, Cook ECL, Hernández-García E, Requena JM, Iborra S. Inoculation of the Leishmania infantum HSP70-II Null Mutant Induces Long-Term Protection against L. amazonensis Infection in BALB/c Mice. Microorganisms 2021;9:363. [PMID: 33673117 DOI: 10.3390/microorganisms9020363] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
Number Citing Articles
1 Yasmin H, Adhikary A, Al-ahdal MN, Roy S, Kishore U. Host–Pathogen Interaction in Leishmaniasis: Immune Response and Vaccination Strategies. Immuno 2022;2:218-54. [DOI: 10.3390/immuno2010015] [Reference Citation Analysis]
2 Solana JC, Moreno J, Iborra S, Soto M, Requena JM. Live attenuated vaccines, a favorable strategy to provide long-term immunity against protozoan diseases. Trends Parasitol 2021:S1471-4922(21)00284-1. [PMID: 34896016 DOI: 10.1016/j.pt.2021.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Parkash V, Kaye PM, Layton AM, Lacey CJ. Vaccines against leishmaniasis: using controlled human infection models to accelerate development. Expert Rev Vaccines 2021;:1-12. [PMID: 34664543 DOI: 10.1080/14760584.2021.1991795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Volpedo G, Huston RH, Holcomb EA, Pacheco-Fernandez T, Gannavaram S, Bhattacharya P, Nakhasi HL, Satoskar AR. From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection. Expert Rev Vaccines 2021;:1-16. [PMID: 34511000 DOI: 10.1080/14760584.2021.1969231] [Cited by in F6Publishing: 3] [Reference Citation Analysis]